N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis-Reference-Cited by-同舟云学术

N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis

Published:2019-04 Issue: Volume:159 Page:66-71
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

Bellenger Jérôme,Bellenger Sandrine,Escoula Quentin,Bidu Célia,Narce Michel

Funder

INSERM

Regional Council of Bourgogne

European Regional Development Fund

University of Bourgogne

Fondation de France

Valorex

French National Research Agency

Publisher

Elsevier BV

Subject

General Medicine,Biochemistry

Reference61 articles.

1. Metabolic syndrome--what is the clinical usefulness?;Kahn;Lancet,2008

2. Targeting metabolism, insulin resistance, and diabetes to treat nonalcoholic steatohepatitis;Finck;Diabetes,2018

3. Inflammation and metabolic disorders;Hotamisligil;Nature,2006

4. Linking the inflammasome to obesity-related disease;Horng;Nat. Med.,2011

5. Macrophages, inflammation, and insulin resistance;Olefsky;Annu. Rev. Physiol.,2010

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions;Frontiers in Cellular and Infection Microbiology;2024-08-07

2. The nutritional function of active polysaccharides from marine animals: A review;Food Bioscience;2024-04

3. Diet, lifestyle and gut microbiota composition among Malaysian women with gestational diabetes mellitus: a prospective cohort study;Scientific Reports;2024-03-22

4. Advances in therapeutic applications of fish oil: A review;Measurement: Food;2024-03

5. Recent insights on pharmacological potential of lycopene and its nanoformulations: an emerging paradigm towards improvement of human health;Phytochemistry Reviews;2024-02-25